Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 3 Monoclonal Gammopathy of Undetermined Significance 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Multiple Myeloma 2 Uterine Cervical Dysplasia 1 Thrombocythemia, Essential 1 Rectal Neoplasms 1 Psychological Well-Being 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Polycystic Ovary Syndrome 1 Neurofibromatosis 1 1 Neoplasms 1 Myelodysplastic Syndromes 1 Motor Activity 1 Lung Neoplasms 1 Joint Diseases 1 Gastritis, Atrophic 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Castration Sensitive Prostate Cancer 1 Breast Neoplasms 1 Arthralgia 1

Interventions

AZD 6244 12 trametinib 4 mirdametinib 2 fludarabine 2 Lasers, Solid-State 2 Inhalation 2 Deoxycholic Acid 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 omipalisib 1 lorlatinib 1 fludarabine phosphate 1 encorafenib 1 dabrafenib 1 cabozantinib 1 binimetinib 1 abemaciclib 1 Waiting Lists 1 Vincristine 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Radiation 1 Polidocanol 1 N-monoacetylcystine 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Liquid Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Curcumin × 1 year × Clear all

NCT05363267 2026-06-01

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡